Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 1

Sponsor Class

INDIV 2OTHER 1

Study Type

Interventional 279Observational 3Expanded_access 1

Sponsor

Conditions

Myasthenia Gravis 3

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Tacrolimus × Clear all
NCT04182984 2026-01-30

TREAT-OMG

Tang-Du Hospital

Recruiting
200 enrolled

Myasthenia Gravis

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

NCT04768465 2021-02-24

Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis

Da, Yuwei, M.D.

Unknown
160 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡